https://platform.ontopharmatech.com/monitoring 2026-08-24 hourly 1.0 https://platform.ontopharmatech.com/pricing 2026-08-24 monthly 0.7 https://platform.ontopharmatech.com/mcp-connect 2026-08-24 monthly 0.7 https://platform.ontopharmatech.com/privacy 2026-08-24 yearly 0.3 https://platform.ontopharmatech.com/terms 2026-08-24 yearly 0.3 https://platform.ontopharmatech.com/news/pharma-marketers-need-a-share-of-answer-strategy-before-ai-spend-0d657a90 2026-08-24 monthly 0.6 https://platform.ontopharmatech.com/news/everything-sprouts-llc-recalls-alfalfa-sprouts-due-to-potential-e-coli-and-salmo-2820a64b 2026-08-22 monthly 0.6 https://platform.ontopharmatech.com/news/fromm-family-foods-voluntarily-recalls-turkey-p-t-wet-food-for-dogs-and-diner-cl-bfd21e6e 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/40th-anniversary-of-the-generic-drug-approval-pathway-1f6135df 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/compounding-and-the-fda-questions-and-answers-16c60197 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/generic-drugs-questions-answers-e4b67a00 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/compounding-information-for-states-575ff353 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/rulemaking-history-for-otc-sunscreen-drug-products-6dc7833b 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/generic-drugs-103f91cd 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/science-research-1e205096 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/complex-generics-news-9cd914c3 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/what-is-the-approval-process-for-generic-drugs-8186c959 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/industry-resources-9910fe9f 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/approvals-reports-535ee536 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public--3a924402 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/biosimilar-and-interchangeable-biosimilar-products-considerations-for-container--f9fe2411 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-guidance-on-pharmacovigilance-procedures-c4ac5452 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/shareholder-pressures-capricor-lilly-dives-deeper-into-vaccines-7302ac66 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/fda-publishes-new-product-specific-guidances-to-facilitate-generic-drug-developm-4badfd2f 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/evaluation-of-therapeutic-equivalence-5fe3f114 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/aisys-cs-and-carestation-32567351 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/iq200-series-analyzers-and-dxu-840m-850m-iris-analyzers-8b70a876 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/foresight-oximeter-cable-0c5d37d7 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/how-cost-and-perception-could-reshape-the-glp-1-market-6d1104f6 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-epidural-kit-issue-from-medical-action-industries-50680f15 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-portrait-core-services-software-issue-from-ge-healthcare-b224215e 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-breathing-circuit-issue-from-medline-2b39a3ac 2026-08-21 monthly 0.6 https://platform.ontopharmatech.com/news/the-south-african-health-products-regulatory-authority-reaffirms-the-safety-of-r-ca6da42c 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/regeneron-to-challenge-ipsen-as-fda-clears-bone-disease-drug-b3130524 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/cancer-vaccine-win-restores-wall-street-s-faith-in-moderna-644bcc1d 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/ultragenyx-after-setbacks-nabs-first-gene-therapy-approval-ca08aca0 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-zentiva-pharma-uk-limited-fingolimod-zentiva-0-5-mg-cap-99334aa8 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-and-template-for-industry-on-implementing-shortage-prevention-plans-spp-3fe5308f 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/centricity-enterprise-archive-and-pacs-workstation-ff8cc37d 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/theragun-pro-333f6890 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/patient-information-centre-ix-5bfc2200 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/convenience-kit-recall-medline-issues-correction-for-convenience-kits-containing-81d29fe8 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/optimal-balance-pharmacy-issues-voluntary-nationwide-recall-of-certain-lots-of-c-616e001b 2026-08-20 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-first-therapy-for-patients-aged-8-years-and-older-with-glycogen-sto-2043333b 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/prince-bakery-inc-issues-allergy-alert-on-undeclared-milk-and-sesame-in-prince-b-a69abba9 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/postmarketing-requirements-and-commitments-reports-ea08f158 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/angiotensin-converting-enzyme-inhibitor-induced-angioedema-risk-of-serious-and-f-98bd10ad 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/patient-listening-session-summaries-3e96bcb3 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/fda-authorizes-first-of-its-kind-robotic-blood-draw-device-e51d7664 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-second-treatment-for-fibrodysplasia-ossificans-progressiva-bb105cb5 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/trump-reportedly-plans-to-tap-policy-aide-overton-to-lead-fda-3bd521ff 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/generic-drug-research-related-guidances-reports-24279ac9 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/completed-pdufa-vii-deliverables-66f133f0 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/moderna-and-merck-cancer-vaccine-returns-landmark-result-in-melanoma-b5f0dceb 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/spectralis-with-flex-module-5ff5ca14 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/embosphere-microspheres-syringe-0e890201 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/statstrip-glucose-and-beta-ketone-hospital-meter-b763468c 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/ema-procedural-advice-for-medicinal-products-intended-exclusively-for-markets-ou-5a6b2e59 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/b-braun-medical-inc-issues-voluntary-north-american-recall-of-excel-lactated-rin-fdbd9db3 2026-08-19 monthly 0.6 https://platform.ontopharmatech.com/news/updated-dreyer-s-grand-ice-cream-inc-issues-voluntary-recall-on-select-outshine--cf18a57e 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/partner-with-us-to-help-more-providers-prescribe-with-confidence-2188874c 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/antiseptic-fda-letters-710a4cc0 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/antiseptic-meetings-35d9d549 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/topical-antiseptic-drug-products-dd2a4c9a 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/esbelta-intense-loss-may-be-harmful-due-to-hidden-ingredients-00c5d9b0 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/esbelta-chupapanza-flat-belly-may-be-harmful-due-to-hidden-ingredient-ad5ae568 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/orange-book-data-files-1911e066 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/prescription-drug-user-fee-amendments-02954528 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/biomarin-acquires-experimental-drug-for-rare-bone-disorder-in-275m-deal-1e3468ec 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/astrazeneca-scores-in-lung-cancer-sandoz-inks-a-china-deal-5dbeb6f9 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/leo-pharma-buys-rare-skin-disease-drug-in-435m-deal-b8856c2e 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/frequently-requested-or-proactively-posted-compliance-records-7a642e70 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/eugia-pharma-specialities-limited-730469-08-13-2026-0eb9bf10 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/k-c-pharmaceuticals-inc-729870-08-12-2026-637ef878 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/suretec-innovations-llc-730122-08-13-2026-fba133b2 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/auriga-research-pvt-ltd-730694-08-12-2026-c1d7630c 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/safrel-pharmaceuticals-llc-730520-08-07-2026-e696b334 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-advises-against-the-use-of-rectal-catheters-in-infants-0e45be3f 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/all-rectal-catheters-gas-and-colic-relievers-do-not-use-in-infants-including-for-e44c9734 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/unauthorized-drugs-seized-from-rabais-4saisons-inc-in-montreal-qc-may-pose-serio-227d76fa 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-10-to-14-august-2026-8a1c8ffc 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/amylyx-s-bet-on-a-glp-1-blocker-pays-off-190c2612 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-sets-out-position-on-regulation-of-microbiome-based-medicinal-products-49abf9a0 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/policy-paper-uk-position-paper-on-microbiome-based-medicinal-products-mbmps-5fc54077 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-convenience-kit-issue-from-becton-dickinson-562f7525 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/l-nutra-issues-allergy-alert-on-undeclared-tree-nuts-in-prolon-brand-apulian-alm-2716a902 2026-08-18 monthly 0.6 https://platform.ontopharmatech.com/news/updated-oma-s-pride-voluntarily-recalls-one-lot-of-woof-complete-canine-chicken--6162aa1b 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/fda-public-meeting-fda-led-patient-focused-drug-development-meeting-for-nonheali-136949be 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/fda-drug-competition-action-plan-improving-the-efficiency-of-the-generic-drug-de-a9175a3f 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/fda-drug-competition-action-plan-08c25fba 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/determining-whether-to-submit-an-anda-or-a-505-b-2-application-07e5dee0 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/argenx-jumps-on-phase-3-data-for-blockbuster-vyvgart-7175e898 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/eyepoint-plummets-on-pivotal-data-for-main-drug-a730de2d 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/astrazeneca-scraps-phase-3-trial-of-new-bispecific-in-lung-cancer-4f47fedd 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/determining-whether-to-submit-an-anda-or-a-505-b-2-application-243fb1a1 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/slate-fulcrum-to-combine-in-reverse-merger-09c8c3d1 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/fda-nod-is-just-the-first-hurdle-for-moderna-s-potential-blockbuster-flu-vax-dac5a6d5 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-consultation-on-statutory-fees-2026-72276829 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/cook-medical-hemospray-kit-a38caa53 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/lactated-ringer-s-injection-usp-presence-of-particulate-matter-be7516dd 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/national-patient-safety-alert-resmed-astral-100-and-150-ventilators-potential-fo-ef9d38a1 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-clinical-trials-phase-1-14-day-pilot-programme-f652f4be 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/sahpra-inspires-tut-students-to-pursue-careers-in-health-regulation-b86ca4c7 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/intraosseous-needle-set-recall-becton-dickinson-removes-certain-intraosseous-vas-4b921d0e 2026-08-17 monthly 0.6 https://platform.ontopharmatech.com/news/sahpra-recalls-certain-batches-of-enalapril-10-mg-used-to-treat-high-blood-press-68139bae 2026-08-16 monthly 0.6 https://platform.ontopharmatech.com/news/two-lots-of-teva-pregabalin-150-mg-capsules-recalled-due-to-cross-contamination--6151cc42 2026-08-15 monthly 0.6 https://platform.ontopharmatech.com/news/the-hampton-grocers-inc-recalls-it-s-8-ounce-packages-of-lacnola-lactation-grano-076f9578 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/addressing-the-public-health-effects-of-opioid-medications-09-09-2026-1d1b674d 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/exotique-foods-inc-recalls-momchipz-veggie-chips-broccoli-florets-cauliflower-du-f276fed5 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/the-center-for-research-on-complex-generics-315ac7c5 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/fda-center-for-research-on-complex-generics-crcg-workshop-on-advancing-bioequiva-66f35478 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/bristol-myers-wins-milestone-fda-approval-of-myeloma-drug-acquired-from-celgene-a95d240e 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/withdrawn-cancer-accelerated-approvals-cb671d66 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/container-closure-systems-for-human-drugs-and-biological-products-11d2976f 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/public-meeting-on-the-recommendations-for-reauthorization-of-the-prescription-dr-634bcd42 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/capricor-shares-spike-on-ceo-comments-cytokinetics-sues-bristol-myers-a91a4d39 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/endotracheal-tube-cuffed-c355a492 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/orthopaedic-implant-components-a9bf23fa 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/vimseltinib-romvimza-approved-for-use-in-adults-to-treat-tenosynovial-giant-cell-2a24fdf1 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/biotech-initiatives-pick-up-as-more-regions-race-to-become-hubs-fba058b6 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/medicines-get-scientific-advice-from-the-mhra-e0d2538f 2026-08-14 monthly 0.6 https://platform.ontopharmatech.com/news/completed-bsufa-iii-deliverables-ff6e1175 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/fda-grants-accelerated-approval-to-iberdomide-with-daratumumab-and-hyaluronidase-169c4331 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/updated-grand-central-bakery-seattle-recalls-potato-sourdough-bread-due-to-possi-f38401b5 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/grand-central-bakery-recalls-potato-sourdough-bread-due-to-possible-foreign-obje-4276e78e 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/medical-products-for-rare-diseases-and-conditions-b9ae9b36 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/small-business-assistance-f49f4e0b 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/phase-1-investigational-new-drug-ind-navigator-0f5896d3 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/upcoming-el-pfdd-meetings-2ba5aadc 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/condition-specific-meeting-reports-and-other-information-related-to-patients-exp-fc03be99 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/fda-issues-emergency-use-authorization-for-drug-to-treat-new-world-screwworm-in--dfbb1dce 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/new-taiho-cullian-data-heats-up-lung-cancer-drug-battle-ab832b1a 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/ptc-takes-a-chance-on-sangamo-s-fabry-disease-gene-therapy-5744a11a 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/information-regarding-insulin-storage-and-switching-between-products-in-an-emerg-5a3e5f26 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/laboratory-information-bulletins-53fc7f58 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/nitrosamine-impurities-acceptable-intake-update-6511aa19 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/covid-19-test-approval-how-to-apply-52195636 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/you-ve-got-the-grades-but-don-t-pass-on-your-health-cd30f716 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-mhra-quarterly-results-and-forecast-2026-to-2027-42e32bcd 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/portrait-core-services-cssxb-9b5d4e63 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/iv-tubing-set-drip-chambers-010e54e2 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/intravascular-administration-set-recall-baxter-removes-duo-vent-solution-sets-6f309de8 2026-08-13 monthly 0.6 https://platform.ontopharmatech.com/news/oma-s-pride-voluntarily-recalls-one-lot-of-woof-complete-canine-chicken-recipe-6-fcb39b3d 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/kettle-cuisine-recalls-marketside-tomato-bisque-soup-kit-sold-exclusively-at-wal-6a2e5901 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/prescription-to-nonprescription-switch-list-drugs-cffd05be 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/anaconda-premium-500k-may-be-harmful-due-to-hidden-ingredient-0e5890bf 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/premium-orgazen-10000-may-be-harmful-due-to-hidden-ingredient-8f7dbf85 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/hardie-s-fresh-foods-recalls-jalapenos-because-of-possible-health-risk-e021cb9f 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/prescription-to-nonprescription-rx-to-otc-switches-932a3b4f 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/prescription-to-nonprescription-switch-list-c86024bd 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/whole-foods-market-announces-a-recall-of-select-salsas-guacamole-pico-de-gallo-a-b19619bd 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/weight-loss-product-notifications-1c3962c5 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/b-magi-may-be-harmful-due-to-hidden-ingredients-4611b8cf 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/dmagic-plus-may-be-harmful-due-to-hidden-ingredients-5953985e 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/lilly-files-six-lawsuits-in-bid-to-shut-down-black-market-for-retatrutide-b7a2d10f 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/activities-report-of-the-generic-drug-program-fdara-title-viii-sections-807-and--ffa142a1 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/q3c-r8-impurities-guidance-for-residual-solvents-3576e3bd 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/psychedelics-developer-definium-scores-more-positive-data-for-lsd-pill-7c80ad5c 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/consultation-on-improving-the-sharing-of-information-about-medical-devices-85f136ff 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/non-compliance-letters-under-505b-d-1-of-the-federal-food-drug-and-cosmetic-act-39c0c77c 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/assessment-of-the-use-of-patient-experience-data-in-regulatory-decision-making-d51274ef 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/table-of-pharmacogenomic-biomarkers-in-drug-labeling-88eb9e8f 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/silence-cashes-in-on-differentiated-data-uk-reaffirms-support-for-childhood-vacc-b09378b9 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/formal-meetings-between-the-fda-and-sponsors-or-applicants-of-pdufa-products-3110efdf 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/unauthorized-injectable-health-products-sold-online-and-seized-from-dyosa-beauty-92da32c5 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/pms-irbesartan-affected-lot-may-contain-pms-irbesartan-hctz-150-12-5-mg-tablets-024402e8 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-reaffirms-the-safety-of-childhood-vaccination-168ea091 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/boulevard-starts-up-with-65m-to-pursue-targeted-autoimmune-drugs-100ae3a6 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/product-management-services-pms-implementation-of-international-organization-for-cedbe959 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/product-management-services-pms-implementation-of-international-organization-for-f0c7c0ac 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/update-on-alert-convenience-kit-issue-from-medline-e25acf49 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/convenience-kit-correction-medline-issues-correction-for-convenience-kits-contai-bee0fb11 2026-08-12 monthly 0.6 https://platform.ontopharmatech.com/news/recall-of-jalapeno-avocado-dressing-because-of-possible-health-risk-9eaa91c6 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/lidl-us-recalls-vitasia-asian-style-wok-spice-mix-due-to-potential-salmonella-co-c9d31f3b 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/public-notification-detoxi-slim-contains-hidden-drug-ingredient-1bd8f3e4 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/over-the-counter-otc-nonprescription-drugs-4f588e51 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/cderlearn-8923e2cd 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/ex-legend-ceo-takes-helm-at-biotech-startup-scouring-the-globe-for-drugs-ac65ac3d 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/drug-trials-snapshots-71ca5d26 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/drug-trials-snapshots-icotyde-b6e9bcc4 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/henkel-corp-announces-a-nationwide-recall-of-schwarzkopf-professional-osis-grip--ed0754fa 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/frankie-s-organic-issues-allergy-alert-on-undeclared-milk-in-frankie-s-organic-p-30899118 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/chasing-dupixent-a-biotech-aims-to-make-better-antibody-drugs-for-eczema-ca56a7c7 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/omni-tract-surgical-retractor-system-29777a1f 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/epicrispr-lands-90m-to-advance-epigenetic-editing-drug-for-rare-muscle-disease-ef3beefa 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/trump-signs-order-seeking-to-upend-childhood-vaccine-schedule-3afb7ea6 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/vaderis-hauls-in-152m-to-test-an-akt-targeting-drug-9dfdd335 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-medicines-and-healthcare-products-regulatory-agency-spending-o-4c07f82b 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-medicines-and-healthcare-products-regulatory-agency-gpc-spendi-14d538f1 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-medicines-and-healthcare-products-regulatory-agency-gpc-spendi-d683ffcd 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-3-to-7-august-2026-8b7de3a5 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/fresenius-kabi-issues-nationwide-recall-of-tyenne-tocilizumab-aazg-injection-400-396a3f9c 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/breathing-circuit-set-recall-hamilton-medical-removes-breathing-circuit-set-8a5274d8 2026-08-11 monthly 0.6 https://platform.ontopharmatech.com/news/drug-compliance-programs-ca4bc89f 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/fiscal-year-2026-generic-drug-science-and-research-initiatives-public-workshop-0-22a50bee 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/over-the-counter-monograph-drug-user-fee-program-omufa-1cff9c6c 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/sionna-cystic-fibrosis-drug-fails-key-trial-removing-threat-to-vertex-5f1d6b92 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/jazz-to-buy-rare-epilepsy-drugmaker-in-potentially-1-3b-deal-12e5a904 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/cder-leadership-bios-c4b8468a 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/advancing-generic-drug-development-modernizing-bioequivalence-approaches-for-top-48d6bc19 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/advancing-generic-drug-development-leveraging-model-integrated-evidence-mie-in-t-d2f2d17b 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/communicating-drug-interaction-and-qtc-information-in-the-u-s-prescribing-inform-0161843f 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/clinicaltrials-gov-essentials-for-academic-medical-centers-07-14-2026-8567c085 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/scribe-s-benjamin-oakes-on-a-rare-ipo-and-bringing-crispr-to-the-masses-edd27af4 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/gdufa-iv-fiscal-years-2028-2032-8373d293 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/public-meeting-on-the-reauthorization-of-generic-drug-user-fee-amendments-gdufa--245aca7f 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-advises-quarantine-of-medical-devices-supplied-without-appropriate-conformi-072f7420 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/devices-supplied-without-valid-ukca-ce-conformity-markings-or-certification-remo-e43e09e1 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/uk-first-in-europe-to-authorise-orforglipron-for-weight-management-and-type-2-di-b1396a4f 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/regulatory-operations-the-overlooked-half-of-submission-readiness-3252adf0 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/catheter-introducer-correction-abiomed-and-oscor-issue-correction-for-catheter-i-991e55d7 2026-08-10 monthly 0.6 https://platform.ontopharmatech.com/news/taylor-fresh-foods-recalls-products-made-with-jalapeno-peppers-because-of-possib-6ddd5332 2026-08-09 monthly 0.6 https://platform.ontopharmatech.com/news/naturebest-precut-produce-llc-voluntarily-recalls-products-containing-jalapenos--62a548d8 2026-08-08 monthly 0.6 https://platform.ontopharmatech.com/news/baxter-issues-voluntary-nationwide-recall-of-cefazolin-in-dextrose-injection-usp-f06c0616 2026-08-08 monthly 0.6 https://platform.ontopharmatech.com/news/lexunder-inc-recalls-food-to-live-brand-green-powder-products-because-of-possibl-ea02b429 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/covid-19-real-world-data-rwd-data-elements-harmonization-project-9647b076 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/sunscreen-meetings-6ad25e23 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/good-laboratory-practice-glp-for-safety-tests-on-chemicals-cc6b5098 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/taking-medication-this-summer-what-you-need-to-know-about-sun-and-heat-exposure-0e40f3fb 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/m11-clinical-electronic-structured-harmonised-protocol-0e6d0465 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/over-the-counter-otc-drug-review-otc-monograph-reform-in-the-cares-act-8c170e13 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/nonprescription-drug-product-with-an-additional-condition-for-nonprescription-us-e4fae0ae 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/ongoing-cancer-accelerated-approvals-348b900d 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/significant-demand-for-revolution-drug-intellia-pinpoints-liver-toxicity-culprit-e6d72176 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/why-big-pharma-is-chasing-the-industry-s-most-powerful-supercomputer-019dd801 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/fda-issues-emergency-use-authorization-for-drug-to-prevent-new-world-screwworm-i-1ff1e0a0 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/bravo-capsule-delivery-system-5521ad37 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/latigo-ipo-raises-nearly-350m-for-pain-drug-development-485b4d68 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/teva-ectosone-0-1-cream-affected-lot-may-be-missing-lot-number-and-expiry-date-161b1627 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-on-implementing-shortage-prevention-plans-spp-20b1f5e9 2026-08-07 monthly 0.6 https://platform.ontopharmatech.com/news/cder-nitrosamine-impurity-acceptable-intake-limits-8506ea70 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/replimune-rebounds-to-win-fda-approval-of-melanoma-drug-4602cfac 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/thrive-health-and-wellness-llc-dba-thrive-health-solutions-714891-07-27-2026-48e1db7f 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/thrive-health-and-wellness-llc-dba-thrive-health-solutions-714891-02-09-2026-7420c07a 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-new-engineered-viral-immunotherapy-for-patients-with-treatment-resi-3ded5308 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/fda-grants-accelerated-approval-to-vusolimogene-oderparepvec-wtpg-in-combination-1ccb1717 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/july-23-24-2026-meeting-of-the-pharmacy-compounding-advisory-committee-07-23-202-40646b49 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/global-calcium-house-1-692000-07-30-2026-3390bada 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/global-calcium-pvt-limited-692000-01-16-2025-c5d777fd 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/first-generic-drug-approvals-76bc38d6 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/learning-and-education-to-advance-and-empower-rare-disease-drug-developers-leade-856d2582 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/alkeus-an-unorthodox-eye-drug-startup-acquired-by-tarsus-for-up-to-800m-690a5a92 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/takeda-approval-ushers-in-new-wave-of-sleep-drugs-b34ec8eb 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/erica-schwartz-confirmed-as-next-cdc-director-88970a25 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-approves-remibrutinib-for-adults-with-chronic-spontaneous-urticaria-4560f30b 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/with-263m-lifemine-unearths-a-new-drug-for-organ-transplants-b51da9c1 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/belzer-uw-cold-storage-solution-and-belzer-mps-uw-machine-perfusion-solution-man-44f42974 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/one-lot-of-new-roots-herbal-probiotic-intensity-recalled-due-to-incorrect-no-dai-86d2c333 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/healon-endocoat-pro-358becd2 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/beckman-coulter-au-immunochemistry-system-au480-analyzer-3327555e 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-moderna-s-mrna-flu-vaccine-ca6ea930 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/medline-industries-lp-issues-nationwide-recall-of-hudson-rci-neonatal-infant-hea-89160efa 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/cardiac-drug-developer-braveheart-banks-more-than-382m-in-ipo-63970f14 2026-08-06 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-first-drug-to-treat-the-full-range-of-narcolepsy-type-1-symptoms-2c79f765 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/decision-advertising-investigations-july-2026-fc15044c 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/attovia-adds-to-biotech-ipo-momentum-with-289m-offering-89224868 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/lilly-climbs-novo-falls-as-obesity-drug-battle-intensifies-f7fc1337 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/earnings-roundup-gilead-s-uncertain-future-pfizer-s-crossroads-and-merck-s-pcsk9-6d516461 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/sun-noodle-issues-voluntary-recall-of-sura-tanmen-hot-and-sour-flavor-premium-ja-63ebf832 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/1788-4k-camera-d97d3675 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/med-rx-wound-care-kits-6715ff11 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/a-copd-drug-from-china-draws-115m-in-venture-funding-192670d7 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/fresenius-kabi-issues-voluntary-nationwide-recall-of-one-lot-of-morphine-sulfate-1d0fc03d 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/victory-medical-center-pharmacy-issues-voluntary-nationwide-recall-of-certain-lo-6f2e36f4 2026-08-05 monthly 0.6 https://platform.ontopharmatech.com/news/blank-slate-creamery-issues-allergy-alert-on-undeclared-egg-in-vegan-non-dairy-f-94540cf3 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/vertex-s-biggest-overhang-a-rival-50-times-smaller-de067f8b 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/pfizer-expands-multibillion-dollar-cost-cutting-plan-9e432c8e 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-27-to-31-july-2026-abb3e6bd 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/j-j-pharma-leader-to-retire-krystal-slumps-on-gene-therapy-miss-c3578c6a 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/dr-ger-atlan-anaesthesia-workstations-risk-of-ventilator-failure-dsi-2026-005-38e8fa71 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/needle-kit-for-powered-driver-1ea82882 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/the-innovative-licensing-and-access-pathway-grants-innovation-passports-to-inves-ef4e25d0 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-intraosseous-needle-set-issue-from-becton-dickinson-6d53d901 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/liebel-flarsheim-company-llc-issues-recall-of-optiray-imaging-bulk-package-350-5-4d06e6fa 2026-08-04 monthly 0.6 https://platform.ontopharmatech.com/news/an-astrazeneca-bristol-myers-megamerger-wall-street-isn-t-thrilled-b0ea1bcc 2026-08-03 monthly 0.6 https://platform.ontopharmatech.com/news/biontech-taps-sobi-executive-oelkers-as-its-next-ceo-93803198 2026-08-03 monthly 0.6 https://platform.ontopharmatech.com/news/supernus-individor-merge-to-beef-up-brain-drug-portfolio-bc0e8ce9 2026-08-03 monthly 0.6 https://platform.ontopharmatech.com/news/boticelli-foods-recalls-bettergoods-pistachio-nut-butter-because-of-possible-hea-c578e5b8 2026-08-03 monthly 0.6 https://platform.ontopharmatech.com/news/bd-issues-nationwide-recall-for-specific-lots-of-bd-intraosseous-vascular-access-8cab42b7 2026-08-03 monthly 0.6 https://platform.ontopharmatech.com/news/american-regent-inc-animal-health-issues-nationwide-recall-of-two-lots-of-adequa-da0f4469 2026-08-03 monthly 0.6 https://platform.ontopharmatech.com/news/convenience-kit-correction-medline-issues-correction-for-kits-containing-huons-l-a548878a 2026-08-03 monthly 0.6 https://platform.ontopharmatech.com/news/convenience-kit-correction-medical-action-industries-issues-correction-for-kits--6d9da2ec 2026-08-03 monthly 0.6 https://platform.ontopharmatech.com/news/trump-administration-tries-again-to-institute-rebates-in-340b-4e9aaf84 2026-07-31 monthly 0.6 https://platform.ontopharmatech.com/news/novo-setback-casts-doubt-on-a-new-way-to-treat-heart-disease-317a26f9 2026-07-31 monthly 0.6 https://platform.ontopharmatech.com/news/resilience-and-lilly-invest-750m-to-boost-cincinnati-drug-production-77244b9b 2026-07-31 monthly 0.6 https://platform.ontopharmatech.com/news/sanofi-to-rebuild-trust-with-regeneron-apnimed-adds-to-string-of-upsized-biotech-8d7d5fc5 2026-07-31 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-mhra-phase-i-accreditation-scheme-585e5512 2026-07-31 monthly 0.6 https://platform.ontopharmatech.com/news/replimune-melanoma-drug-wins-support-of-fda-panel-30b444fc 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/alnylam-plunges-as-earnings-deliver-one-two-punch-c282e2a7 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/ftc-sues-hims-hers-over-alleged-privacy-violations-deceptive-billing-practices-b00ff53e 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/j-j-nabs-option-to-buy-in-vivo-car-t-maker-sail-for-nearly-2-6b-a75d089b 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/new-leadership-team-appointments-a1fbc86f 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-safety-roundup-july-2026-8ea1a6fd 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/pharmasave-regular-strength-dairy-digestive-supplement-lactase-enzyme-affected-l-5b6d318f 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/femyso-affected-lot-may-contain-two-green-mifepristone-cartons-or-two-pink-misop-53210c46 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-development-of-a-reflection-paper-on-the-non-clinical-requi-2776b9f7 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-magnetic-resonance-imaging-equipment-in-clinical-use-safety-guidelines-0b7e55a1 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/thousands-of-patients-to-benefit-from-new-daily-pill-for-serious-heart-condition-d152ed95 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-london-region-i-mhra-regulatory-sandbox-call-for-expressions-of-interes-01c480b9 2026-07-30 monthly 0.6 https://platform.ontopharmatech.com/news/capricor-duchenne-cell-therapy-voted-down-by-fda-panel-afde0d59 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/maplight-ceo-on-what-investors-missed-in-the-biotech-s-schizophrenia-data-2f07f726 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/caldera-vidya-add-to-recent-flurry-of-biotech-mergers-6afeb4ef 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/abcellera-vertex-partner-on-next-gen-t-cell-engagers-71d2c85d 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-clarifies-regulatory-status-of-ambient-voice-technologies-used-in-the-nhs-ba990fb9 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/earnings-roundup-biogen-s-resiliency-astrazeneca-s-growth-pitch-and-gsk-s-oncolo-1a0e7af7 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/fda-reviewers-criticize-replimune-drug-promis-climbs-on-alzheimer-s-data-8b6620f1 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/azurion-systems-6d0cd5d8 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/beat-the-heat-mhra-urges-people-to-take-extra-care-with-medical-devices-this-sum-8d815dfc 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-ambient-voice-technology-enabled-products-6e83e028 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-digital-mental-health-technology-qualification-and-classification-776dda2e 2026-07-29 monthly 0.6 https://platform.ontopharmatech.com/news/registered-outsourcing-facilities-a0a974b9 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/upcoming-product-specific-guidances-for-generic-drug-product-development-3087f8b0 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/gsk-prepares-for-patent-cliff-with-2-5b-cost-cutting-plan-3d303cee 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/new-approach-methodologies-nams-7f6feaf2 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/ahc-products-inc-728604-06-12-2026-fb5bca76 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/fda-publishes-revised-draft-product-specific-guidances-for-certain-generic-pepti-fcd6e88c 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/withdrawn-and-expired-guidances-drugs-2690e584 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/blanketrol-ii-115v-and-blanketrol-iii-115v-189b54ff 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/iqecg-digital-ecg-c3af92f5 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/the-fda-was-all-in-on-ai-will-that-change-ad9020a9 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/an-eye-drug-biotech-banks-118m-and-stocks-its-executive-suite-3ee71ddd 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-20-to-24-july-2026-6e19c82f 2026-07-28 monthly 0.6 https://platform.ontopharmatech.com/news/ectd-submission-standards-for-ectd-v4-0-and-regional-m1-ad0f632a 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/electronic-registration-and-listing-compliance-program-011476cb 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/cder-patient-focused-drug-development-224874c9 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/maplight-dives-despite-positive-data-for-schizophrenia-drug-ebc0bf18 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/expedited-ind-pilot-program-educational-webinar-for-stakeholders-08-06-2026-1c03df94 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/novel-drug-approvals-for-2026-f97f4049 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/fda-actions-to-accelerate-and-modernize-early-and-late-stage-clinical-developmen-e067dec8 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/argenx-to-acquire-forte-in-2-2b-deal-for-differentiated-immune-drug-ddad3f59 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/who-integration-innovation-and-community-leadership-key-to-ending-hiv-hepatitis--bf6a25fe 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/fda-scientists-question-capricor-data-legend-ceo-steps-down-c9578f88 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/sarepta-in-search-of-a-turnaround-taps-ex-abbvie-exec-severino-as-ceo-abac1ef7 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/safety-public-assessment-reports-4c37fd8e 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/research-bladder-anticholinergics-review-of-risk-of-dementia-61884adf 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/draft-guideline-on-veterinary-good-pharmacovigilance-practices-vgvp-module-pharm-15f2f165 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/spacelabs-healthcare-xhibit-central-station-8709663f 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/sphere-9-catheter-b4752042 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/harmonic-arts-holy-basil-tincture-out-of-specification-total-aerobic-microbial-c-3d5a8b6f 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/patient-tables-of-philips-allura-and-azurion-systems-dcaf40a8 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/podcast-season-2-the-progress-profile-alzheimer-s-research-in-focus-5352d495 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/from-confidence-to-capital-positioning-biotech-for-the-next-growth-cycle-9c6efebb 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/american-regent-inc-issues-voluntary-nationwide-recall-of-one-lot-of-papaverine--e9d3bdb6 2026-07-27 monthly 0.6 https://platform.ontopharmatech.com/news/sanofi-halts-development-of-troubled-immune-drug-in-eczema-2b7e98d3 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/novo-escalates-legal-fight-with-lilly-j-j-reinforces-dominance-in-multiple-myelo-6d8670c2 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/list-of-changes-to-combined-veterinary-dictionary-for-drug-regulatory-activities-6f3d0eea 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-quality-and-safety-aspects-of-rna-interference-and-rna-anti-cf55ee00 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/guideline-on-data-requirements-for-changes-to-the-strain-composition-of-authoris-a9cfa626 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp--0fd6f30d 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/no-summer-shortcut-for-safe-weight-loss-690f4f82 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guideline-on-pharmaceutical-fixed-combinati-af4a97d1 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/guideline-on-data-requirements-to-support-in-use-stability-claims-for-veterinary-6240bcd9 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-percutaneous-catheter-issue-from-boston-scientific-2b2f588b 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/sunny-pharmtech-inc-issues-voluntary-nationwide-recall-of-cyclophosphamide-for-i-5684a937 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/baxter-issues-voluntary-nationwide-recall-of-cefazolin-in-dextrose-injection-usp-79981a1f 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/lidl-us-recalls-eridanous-shortbread-cookies-with-chocolate-truffle-coating-apri-bf6c460e 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/scribe-secures-129m-in-a-rare-gene-editing-ipo-603f9f93 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/fda-panel-endorses-broader-use-of-certain-peptides-b71d2718 2026-07-24 monthly 0.6 https://platform.ontopharmatech.com/news/lilly-with-new-data-to-seek-fda-approval-of-obesity-drug-retatrutide-f3b57f37 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/adoption-of-international-scientific-guidelines-in-australia-r01-2025-3ae70b2d 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-clinical-investigations-compiling-a-submission-16b683ec 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-medical-devices-that-need-a-clinical-investigation-9cd97b8b 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-investigations-in-great-britain-6a3efec0 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-approving-clinical-investigations-f24772c4 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/heartsine-samaritan-pad-sam-350p-sam-360p-sam-500p-membrane-tail-4793c3ae 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/overstitch-suture-cinch-and-suture-cinch-long-5aa7cfa8 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-neuraxpharm-uk-ltd-tuzulby-prolonged-relea-a33c5c4c 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/who-launches-seven-strategies-to-prevent-drowning-b3c6fe09 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/midwest-poultry-services-l-p-recalls-shell-eggs-due-to-possible-salmonella-enter-7251cc9f 2026-07-23 monthly 0.6 https://platform.ontopharmatech.com/news/vertex-was-sole-bidder-in-high-premium-crinetics-acquisition-fd1118f7 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/gsk-lung-cancer-drug-gets-speedy-approval-following-10-6b-deal-e110d8f6 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/fda-announces-first-participant-selected-for-tempo-for-digital-health-devices-pi-e2c79895 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/arrowhead-hits-best-case-scenario-with-latest-results-for-fat-lowering-drug-12c39816 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/trump-threatens-tariffs-on-imported-generic-drugs-0103caae 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/summit-counters-pd-1-vegf-skeptics-celldex-drug-fails-skin-disease-study-dd68f02e 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/fda-takes-further-steps-to-remove-outdated-authorizations-for-color-additives-in-d8c746d6 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/heartsine-samaritan-pad-sam-350p-sam-360p-sam-500p-c3fad5bb 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/dca-vantage-hba1c-dx-claim-ac0bcfcb 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/crystalys-nets-130m-more-to-push-gout-drug-through-late-stage-tests-b245399a 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-mhra-policy-for-handling-corporate-conflicts-of-interest-48178bfa 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-revision-of-guideline-on-similar-biological-medicinal-products--647bd622 2026-07-22 monthly 0.6 https://platform.ontopharmatech.com/news/nse-products-inc-dba-nu-skin-enterprises-inc-722667-07-14-2026-087c9d10 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/nse-products-inc-dba-nu-skin-enterprises-inc-722667-03-02-2026-1ff7423a 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/centaur-pharmaceuticals-private-ltd-651080-12-03-2025-50c7272c 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/centaur-pharmaceuticals-private-ltd-651080-06-05-2023-b73c5f16 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/agios-scraps-sickle-cell-drug-205b4fc6 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/novo-sues-lilly-alleging-misleading-advertising-of-obesity-drugs-6a966dde 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/dimension-restocks-with-800m-to-capitalize-on-ai-s-rapid-ascent-8b30f7a7 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/fda-actions-to-support-and-strengthen-domestic-drug-manufacturing-b610ed88 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/novartis-climbs-on-upbeat-drug-sales-as-key-readouts-loom-e7619043 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/q-a-on-cgmp-requirements-ceee8b93 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/written-requests-issued-c48dda3a 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-695821-03-03-2025-4bb766a8 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-679523-07-25-2024-3c5bcf2e 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-662503-12-20-2023-f7eb27b3 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-649056-08-18-2023-19aa6066 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-631751-10-28-2022-25589abb 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-629452-08-04-2022-2a670882 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-665460-11-13-2023-6fc218f5 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-728814-06-17-2026-b00b897b 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/amazon-com-inc-689355-04-17-2025-5deb8830 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/alembic-pharmaceuticals-ltd-731020-07-10-2026-306fdc35 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/island-kinetics-inc-d-b-a-covalence-laboratories-726379-07-16-2026-cb949925 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/domperidone-new-contraindication-in-patients-with-phaeochromocytoma-due-to-the-r-b6c392e5 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/shimadzu-x-ray-high-voltage-generators-40faf459 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/mequ-a-s-m-warmer-leakage-90a028cd 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/cardinal-health-presource-kits-containing-the-ritmed-neurological-sponges-327bf0cd 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-approves-world-s-first-lower-carbon-beclometasone-inhalers-for-patients-wit-b10f8a41 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/un-report-global-hunger-levels-ease-for-third-consecutive-year-as-regional-dispa-2562da34 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-13-to-17-july-2026-2f848058 2026-07-21 monthly 0.6 https://platform.ontopharmatech.com/news/tempus-to-buy-cancer-test-maker-personalis-for-1-5b-8326bc9f 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/tempus-to-acquire-cancer-test-maker-personalis-for-1-5b-43878d01 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/pain-drugmaker-latigo-outlines-plans-to-go-public-0a995b6d 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/who-marks-25-years-of-research4life-advancing-access-to-scientific-knowledge-in--7b75e486 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-macarthys-laboratories-ltd-t-a-martindale--f82fcda1 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/bristol-myers-to-build-powerful-ai-factory-samsung-biologics-bids-for-peptide-ma-82284376 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/philips-achieva-and-ingenia-systems-ca26546a 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/sahpra-inspires-rhodes-science-students-to-shape-the-future-of-health-regulation-ad922d56 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/sahpra-inspires-rhodes-science-students-to-shape-the-future-of-health-regulation-bda1120c 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-medical-devices-legal-requirements-for-specific-medical-products-461f5c18 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-custom-made-medical-devices-in-great-britain-3a32ec64 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/road-deaths-fall-by-21-globally-but-stronger-action-is-needed-to-save-lives-757da80c 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-intravascular-administration-set-issue-from-baxter-bbaad141 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/unique-pharmaceutical-laboratories-a-div-of-j-b-chemicals-pharmaceuticals-ltd-is-9244f29e 2026-07-20 monthly 0.6 https://platform.ontopharmatech.com/news/relay-peak-research-llc-recalls-zen-principle-moringa-capsules-because-of-possib-1635f363 2026-07-19 monthly 0.6 https://platform.ontopharmatech.com/news/who-member-states-continue-negotiations-on-the-pathogen-access-and-benefit-shari-deff2c2c 2026-07-18 monthly 0.6 https://platform.ontopharmatech.com/news/fayus-inc-dba-yusol-international-foods-expands-recall-of-ola-ola-pounded-yam-du-c981014d 2026-07-18 monthly 0.6 https://platform.ontopharmatech.com/news/jasper-gets-a-lifeline-in-merger-with-immune-drugmaker-kira-1f5ea326 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-first-oral-pcsk9-inhibitor-to-lower-ldl-cholesterol-in-adults-with--29cade3a 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/arbutus-sanofi-escalate-mrna-patent-fights-innocare-s-tyk2-contender-advances-09045829 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/compounders-maintain-a-firm-grip-on-the-glp-1-market-fb28dbfa 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/gsk-shelves-cough-drug-acquired-in-2b-deal-11c7614a 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/how-well-are-ai-discovered-drugs-faring-in-the-clinic-c5be334c 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/hot-cars-hot-luggage-why-where-you-store-your-medicines-matters-this-summer-0473b951 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-human-medicines-regulations-2012-advisory-bodies-annual-report--d19b8b96 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/er-spec-single-use-vaginal-speculum-with-led-light-source-8fb70725 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/merge-pacs-ab561422 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/atellica-ch-urine-albumin-ualb-f56bfeab 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/direct-healthcare-professional-communication-dhpc-tavneos-avacopan-recommendatio-46415f45 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-14--58ab1826 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/taylor-fresh-foods-recalls-iceberg-lettuce-from-central-mexico-because-of-possib-e4d8d02f 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/catheter-introducer-kit-recall-abiomed-removes-14fr-low-profile-introducer-kits-667cdca0 2026-07-17 monthly 0.6 https://platform.ontopharmatech.com/news/khong-guan-corporation-issues-recall-of-glutinous-rice-balls-with-black-sesame-f-1f4d1b91 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/pediatric-exclusivity-granted-f90ea97a 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/commissioner-s-national-priority-voucher-cnpv-pilot-program-4f9f27d7 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/bsufa-iv-fiscal-years-2028-2032-9507e2fa 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/mantroforce-729021-06-17-2026-8054e040 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/cder-small-business-industry-assistance-sbia-f4715ea9 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/wholesale-peptide-729447-06-17-2026-49ef5be1 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/texinkart-inc-729046-06-17-2026-406db9d8 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/lilly-to-buy-ataibeckley-for-2-8b-further-validating-psychedelics-c167764a 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/herbal-dermals-llc-fz-dba-gotucream-729043-06-17-2026-f09bc035 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/leading-edge-health-inc-729193-06-17-2026-431a0de6 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/wild-arabic-herbs-729192-06-17-2026-b0607f86 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/hadassah-healing-oils-ltd-729191-06-17-2026-4e28cf10 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/indiangoods-shop-729068-06-17-2026-2a7238fb 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/great-india-overseas-pvt-ltd-dba-silkrute-729065-06-17-2026-234868ea 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/telos-trading-limited-dba-alwinshop-729062-06-17-2026-229fd52f 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/jjlbro-729873-06-17-2026-754bfaa5 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/how-to-spot-health-fraud-bc704274 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/veradermics-keeps-momentum-going-as-baldness-drug-helps-women-with-hair-loss-71407435 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/cder-manual-of-policies-procedures-mapp-e999449f 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/merck-wins-first-approval-of-a-pcsk9-cholesterol-pill-a831f172 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-20-non-pharmacovigilance-procedures-04550cd4 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/recently-issued-guidance-documents-6a32de83 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-13-referral-procedures-93bf6ee1 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/solar-gi-b13718f6 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/philips-allura-xper-fd-series-4765e77f 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/cardiac-workstation-3ce78f9e 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/strykeflow-ps-and-ahto-f2f06fa3 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/v-loc-90-and-180-suture-products-3e762912 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/sema-3-c20e5cf5 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/notable-approvals-drugs-942828ca 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-delivers-record-performance-as-2025-26-annual-report-and-accounts-confirms--73131639 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-29-4-referral-procedures-cd9bf689 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/convenience-kit-correction-arrow-international-issues-correction-for-convenience-37faab6a 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/convenience-kit-recall-b-braun-medical-inc-removes-spinal-anesthesia-kits-contai-05abb9f5 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/khong-guan-corporation-issues-expanded-recall-of-glutinous-rice-balls-with-black-3be16922 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/fda-issues-emergency-use-authorization-for-drug-for-short-term-prevention-of-new-ea96a909 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/celcuity-gains-fda-approval-for-closely-watched-breast-cancer-drug-e4d71211 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/merck-adc-in-china-study-shows-potential-to-replace-chemo-in-lung-cancer-f88dc991 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/braveheart-attovia-join-next-wave-of-biotech-ipos-7d1e0aef 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-30-referral-procedures-d152ec70 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/new-information-relating-to-s-9d-1-applications-for-listed-medicines-62aff2aa 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/updated-warnings-for-botulinum-toxin-products-following-rare-cases-of-botulism-2b48c48a 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-31-non-pharmacovigilance-referrals-f9d39dd0 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/j-j-dips-despite-upbeat-outlook-astrazeneca-spero-cut-china-deals-3e5491a8 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/botulinum-toxin-type-a-products-updated-warnings-regarding-risk-of-iatrogenic-bo-97400d5b 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-52-6b91459d 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/205-2026-5-2026-55-d47a1245 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/3-10-2026-56-03d4ba33 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-50-78487fd6 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-21-6868478a 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-62-a32b8155 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-58-8d5cfb52 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-63-d9b676f9 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/new-who-guidelines-up-to-45-of-dementia-risk-could-be-prevented-or-delayed-3b995473 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-medical-devices-list-of-uk-approved-bodies-9971b358 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/leoni-plus-b64dfc89 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/presource-kits-containing-teleflex-pilling-wecksorb-neurosponge-c1194b3e 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-clinical-trials-regulations-transitional-arrangeme-fdb699bb 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/ema-and-eismea-boost-cooperation-to-accelerate-health-innovations-4101ca55 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-collection-verification-and-reporting-of-safety-ev-faa5c03a 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-medicines-and-healthcare-products-regulatory-agency-annual-repo-f548289b 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/draft-reflection-paper-on-particulars-for-safety-signals-for-traditional-herbal--737d16b3 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/executive-director-emer-cooke-s-speech-at-the-european-parliament-s-committee-on-256814a0 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guidelines-on-good-manufacturing-practice-f-13b6efbe 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guidelines-on-good-manufacturing-practice-f-7aca7f13 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/list-of-substances-and-products-subject-to-worksharing-for-signal-management-f6627342 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-ventilator-issue-from-resmed-af503ecf 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/global-childhood-immunization-coverage-inches-forward-despite-conflict-and-hesit-2a8a7147 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/cvs-caremark-reaches-settlement-with-ftc-over-insulin-suit-1891fb4b 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/judge-orders-apple-tree-partner-to-forfeit-oversight-of-venture-fund-1e862a40 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/fresh-off-buyout-akero-execs-reunite-to-advance-long-acting-psoriasis-pill-4897d7cf 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-international-recognition-procedure-88be4f48 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-medicines-and-healthcare-products-regulatory-agency-privacy-no-f44e99d4 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/draig-bags-another-65m-to-speed-testing-of-brain-drugs-d036266e 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/biogen-data-highlight-promise-questions-surrounding-tau-targeting-alzheimer-s-dr-dc0b0cd6 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/37-2026-57-cf1ef3fb 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/2-2026-24-2aeab6a4 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/2026-25-3c11f7b1 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-6-to-10-july-2026-3712427d 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-in-vitro-diagnostic-point-of-care-test-devices-bf184c57 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/semaglutide-and-flextouch-solution-for-injection-in-pre-filled-pen-product-speci-3b681662 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/positive-pressure-breathing-device-correction-baxter-issues-correction-for-voler-598f8190 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/freenome-colorectal-cancer-test-data-improve-on-earlier-results-86d161aa 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/q32-bounces-back-to-claim-study-success-for-alopecia-drug-5ca0d715 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/agenus-surges-on-study-pivot-apnimed-lines-up-an-ipo-d7d39388 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/register-to-make-submissions-to-the-mhra-fe159bc7 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-beckton-dickson-uk-ltd-chloraprep-1ml-applicator-el-26--c975b7eb 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/oribe-serene-scalp-densifying-shampoo-presence-of-bacterial-contamination-5d75bcd2 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/apo-tiotropium-capsules-out-of-specification-particle-size-0f87a4ac 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/bd-chloraprep-clear-1ml-applicator-product-sterility-350f3fdb 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/biotech-startup-funding-gap-widens-despite-rebound-in-vc-investment-78b14dc6 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/pre-notification-check-for-type-ib-variations-eeb4b453 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-applicants-for-the-preparation-of-the-precise-scope-section-of-the--e3ca7ab1 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/el-salvador-validated-by-who-as-having-eliminated-trachoma-as-a-public-health-pr-e7f34ed3 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/european-medicines-agency-pre-authorisation-procedural-advice-for-users-of-the-c-a2c9b537 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/european-medicines-agency-pre-authorisation-procedural-advice-for-users-of-the-c-00254986 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-on-good-manufacturing-practice-and-good-distribution-practice-questions-e2add771 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/european-medicines-agency-post-authorisation-procedural-advice-for-users-of-the--0fad13b1 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/european-medicines-agency-post-authorisation-procedural-advice-for-users-of-the--2d51db3d 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/pulmonary-valve-catheter-delivery-system-recall-medtronic-removes-harmony-delive-5c8576a5 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/podcast-from-protocol-to-patient-inside-clinical-supply-with-almac-clinical-serv-ab58f659 2026-07-12 monthly 0.6 https://platform.ontopharmatech.com/news/gsk-hansoh-adc-extends-survival-in-lung-cancer-study-ea0349c9 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/fda-proposes-rule-to-modernize-drug-manufacturing-registration-4d5146eb 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/yellow-cards-bad-in-football-brilliant-in-patient-safety-3093a769 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/arpa-h-puts-160m-into-bespoke-drug-therapies-biohaven-switches-up-scientific-lea-23456bc7 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-6-9-b0c1eb02 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/roche-scraps-two-ionis-partnered-huntington-s-drugs-082d3834 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/gsk-ends-brain-drug-alliance-with-alector-f17cfe09 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/access-new-active-substance-and-biosimilar-work-sharing-initiatives-32c605d0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/hhs-plan-to-speed-drug-research-won-t-remove-self-inflicted-delays-d8cdb0a2 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/astral-150-66781c5c 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/m-warmer-10fe2a0d 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/phantom-hindfoot-ttc-tc-ball-tipped-guide-rod-18cca565 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/research-use-of-uk-plasma-for-the-manufacture-of-five-further-plasma-derived-med-ba4113ae 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/astrazeneca-ionis-drug-fails-big-heart-disease-study-in-major-setback-29698a2b 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/heat-travel-and-late-nights-how-summer-can-affect-your-medicines-and-how-to-stay-b752c927 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-safety-review-gives-uk-plasma-donations-go-ahead-1e10d46f 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-bristol-laboratories-limited-phenoxymethylpenicillin-25-7a45bc66 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-9860de94 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-d60a3d23 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-35c64cda 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-c5285b02 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-9124aedb 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/disposiciones-para-la-adquisici-n-y-fabricaci-n-de-ventiladores-durante-la-emerg-fccde067 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/comunicado-a-la-poblaci-n-comisi-n-federal-para-la-protecci-n-contra-riesgos-san-dae259f2 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cofepris-establece-nuevo-sistema-electr-nico-de-citas-comisi-n-federal-para-la-p-a67cee99 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cofepris-elimina-barreras-para-la-producci-n-de-medicamentos-gen-ricos-comisi-n--56679ab6 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cofepris-informa-sobre-la-autorizaci-n-de-pruebas-serol-gicas-comisi-n-federal-p-1e2be072 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/funci-n-p-blica-y-cofepris-colaboran-para-rescatar-de-intereses-privados-el-sect-d68079d8 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/renuevan-m-xico-y-estados-unidos-alianza-por-la-inocuidad-alimentaria-comisi-n-f-d0a7ef47 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nuevo-mecanismo-para-fortalecer-el-mercado-de-medicamentos-gen-ricos-comisi-n-fe-90352341 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/news-ef38e5b8 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/news-bed7baac 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/china-nmpa-and-singapore-hsa-sign-mou-on-regulatory-cooperation-211507d4 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nmpa-commissioner-meets-who-representative-for-enhanced-collaboration-bb0e86e4 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/china-updates-drug-clinical-trial-guideline-to-enhance-biotech-innovation-851cdeb6 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nmpa-deputy-commissioner-meets-australian-ambassador-to-discuss-medical-product--3a7ef639 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nmpa-deputy-commissioner-meets-with-danish-ambassador-and-novo-nordisk-chairman-5a2ae1c1 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nmpa-meeting-on-vaccine-regulatory-qms-and-who-wla-assessment-0bc54fa9 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/ixchiq-chikungunya-vaccine-temporary-suspension-in-people-aged-65-years-or-older-b072d14d 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-determina-apreens-o-de-saneantes-sem-registro-ag-ncia-nacional-de-vigil-n-5faf7298 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-atualiza-listas-de-subst-ncias-para-uso-em-cosm-ticos-ag-ncia-nacional-de-018071e1 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/canais-de-divulga-o-da-anvisa-ser-o-ajustados-durante-per-odo-do-defeso-eleitora-4419f10e 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/entram-em-vigor-os-novos-comp-ndios-da-farmacopeia-brasileira-ag-ncia-nacional-d-1a87224a 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-disponibiliza-nova-ferramenta-para-consulta-de-alertas-sanit-rios-ag-ncia-7d84ab68 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-aprova-nova-indica-o-terap-utica-para-medicamento-que-trata-c-ncer-de-mam-2440267c 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/canetas-do-paraguai-n-o-demonstraram-equival-ncia-com-medicamentos-registrados-n-b3426100 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-realiza-12-reuni-o-ordin-ria-p-blica-da-diretoria-colegiada-ag-ncia-nacio-dc545de5 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-updates-prescribing-medicines-in-pregnancy-database-may-2026-additions-and-a-907778fe 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/lapse-of-provisional-registration-for-andexxa-andexanet-alfa-in-australia-be9bce7a 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-updates-authorised-prescriber-scheme-for-mdma-and-psilocybine-access-6fb0a611 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-updates-permissible-ingredients-for-listed-medicines-in-june-2026-b9409d21 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-updates-listed-medicine-compliance-reports-for-june-2026-cancelling-8-medici-c01d10b1 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/australia-new-udi-requirements-for-medical-devices-commence-1-july-2026-fc5b1359 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/news-articles-therapeutic-goods-administration-tga-40bfb8d8 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/your-request-has-been-blocked-security-incident-8fe85aa8 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-news-articles-regulatory-updates-and-compliance-for-pharma-8a4e38b0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/finasteride-and-dutasteride-updated-safety-warnings-for-psychiatric-side-effects-4902006d 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/hormone-replacement-therapy-hrt-further-information-on-the-known-increased-risk--9fb9ef9e 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/adrenaline-auto-injectors-aais-new-guidance-and-resources-for-safe-use-gov-uk-24263316 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/ondansetron-for-intravenous-use-dose-dependent-qt-interval-prolongation-gov-uk-e567eb10 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/ace-inhibitors-and-angiotensin-ii-receptor-antagonists-not-for-use-in-pregnancy--1376d2b9 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/carbapenems-concomitant-use-with-valproic-acid-not-recommended-gov-uk-c73da8c0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/sitaxentan-thelin-worldwide-withdrawal-from-the-market-gov-uk-0e3051ec 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-august-2023-gov-0023c040 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia-gov-uk-57268ff6 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/part-11-electronic-records-electronic-signatures-scope-and-application-fda-03d25182 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/safety-efficacy-and-pharmacokinetic-studies-to-support-marketing-of-immune-globu-3966b2c0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/premarketing-risk-assessment-fda-47cd8264 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cancer-clinical-trial-eligibility-criteria-washout-periods-and-concomitant-medic-606dfb22 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/pulse-oximeters-for-medical-purposes-non-clinical-and-clinical-performance-testi-85f582d1 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/frequently-asked-questions-statement-of-investigator-form-fda-1572-fda-c4ecf0e0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/redbook-2000-iv-c-4-a-subchronic-toxicity-studies-with-rodents-fda-8769b6c6 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/q2a-text-on-validation-of-analytical-procedures-fda-8dfba1d2 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cpg-sec-562-750-labeling-of-food-articles-distributed-solely-in-puerto-rico-fda-8aedcf24 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/a-risk-based-approach-to-monitoring-of-clinical-investigations-questions-and-ans-0e0edf67 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/astrazeneca-gsk-intensify-china-ties-with-sino-biopharm-deals-b74d52f4 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/four-sentenced-to-nearly-15-years-combined-jail-time-following-major-mhra-invest-debdf851 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/health-regulators-warn-against-the-use-or-dispensing-of-recalled-semaglutide-and-f90fecb6 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/prime-wins-gene-editing-dispute-saol-claims-latest-post-makary-fda-reversal-e6d2e552 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/two-lots-of-omnitrope-injectable-human-growth-hormone-recalled-due-to-cracked-ca-32051eca 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/alice-le-system-sleepware-software-29c949c3 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/allura-xper-fd10-c1b5f827 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/who-calls-for-urgent-action-as-new-cancer-cases-are-projected-to-nearly-double-b-53d29eeb 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/policy-paper-medicines-and-healthcare-products-regulatory-agency-mhra-economic-g-c2014aed 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/nerandomilast-jascayd-approved-to-treat-adult-patients-with-idiopathic-pulmonary-35c1553d 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/oberland-pours-up-to-400m-into-meiragtx-eye-gene-therapies-aa3ddc76 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/kailera-says-obesity-pill-succeeds-in-late-stage-trial-in-china-bb3affe1 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/take-control-of-your-learning-journey-and-understand-your-regulatory-obligations-543598db 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/vertex-to-acquire-crinetics-in-10b-foray-into-endocrine-disease-drugs-982e0ff6 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/ema-fast-tracks-review-of-a-medicine-for-metastatic-pancreatic-cancer-59555ac6 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/vera-therapeutics-wins-fda-nod-for-closely-watched-kidney-disease-drug-068e45d6 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-29-june-to-03-july-2026-630712a4 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/decision-advertising-investigations-june-2026-b6cf1782 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-clinical-trials-for-medicines-roles-and-responsibilities-9e4cb73c 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/decision-doxecitine-and-doxribtimine-in-the-treatment-of-thymidine-kinase-2-defi-2e7e6e03 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/qualification-of-novel-methodologies-for-medicinal-product-development-guidance--4d70508e 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-ending-a-clinical-trial-dcb6e031 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/gene-editing-developer-scribe-plots-an-ipo-b21485c1 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/novartis-to-acquire-adc-developer-in-a-deal-worth-up-to-1-5b-f5821ed4 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/cancer-immune-drugmakers-dominate-vc-funding-so-far-in-2026-414be83a 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/beyond-boston-unlikely-cities-stake-biotech-claims-b32bd12c 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/hotline-iv-fluid-warmer-system-accessories-7dbc6e41 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-mhra-innovation-office-e532675e 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-approves-retifanlimab-zynyz-for-the-treatment-of-advanced-merkel-cell-skin--e7402a7c 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/semaglutide-wegovy-approved-to-treat-form-of-liver-disease-435d3753 2026-07-03 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-best-practice-in-the-labelling-and-packaging-of-medicines-a2a6e1c7 2026-07-03 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-submit-changes-to-labels-and-patient-information-leaflets-as-a-self-cer-182970ff 2026-07-03 monthly 0.6 https://platform.ontopharmatech.com/news/classification-of-products-as-drugs-and-devices-and-additional-product-classific-46f3ee44 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers-309fd289 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/cpg-sec-540-600-fish-shellfish-crustaceans-and-other-aquatic-animals-fresh-froze-34e69652 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/e11a-pediatric-extrapolation-fda-e43b6d10 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/study-of-sex-differences-in-the-clinical-evaluation-of-medical-products-fda-a5abac6e 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/cvm-gfi-224-vich-gl52-bioequivalence-blood-level-bioequivalence-study-fda-306833a2 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/prevention-and-treatment-of-chemotherapy-induced-peripheral-neuropathy-developin-8ea0bfc7 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/fda-alerts-health-care-providers-to-cases-of-neurologic-complications-from-gener-0ae10d8f 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/drug-alerts-and-statements-2ea72e81 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/fda-listing-of-authorized-generics-e542369b 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/generic-drug-user-fee-amendments-83ceaf3d 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/patent-certifications-and-suitability-petitions-16a6e27b 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/who-adds-first-diagnostic-test-for-ebola-bundibugyo-virus-to-its-emergency-use-l-bf6a9e98 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/medicines-apply-for-a-variation-to-your-marketing-authorisation-09220a1d 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/patient-education-bd88d69b 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/a-puretech-startup-banks-180m-for-a-new-ipf-drug-8c97ddaf 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-medicines-that-you-cannot-export-from-the-uk-or-hoard-a146c3d1 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/roche-kras-drug-succeeds-in-head-to-head-lung-cancer-study-64812043 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/making-regulation-a-catalyst-not-a-barrier-for-uk-life-sciences-1298ad81 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/preventing-accidental-apoquel-chewable-overdoses-629f6869 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/ema-steps-up-efforts-on-medicines-for-women-s-health-325908ec 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/competitive-generic-therapy-approvals-0891aec4 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/patient-enrolment-begins-in-a-scientific-trial-to-identify-the-first-effective-t-7cf3e3e0 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/lifecodes-lsa-class-ii-1307d65b 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/nephromax-high-pressure-nephrostomy-balloon-catheter-0f9fc7db 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/fludeoxyglucose-18f-injection-cracket-vial-38c4c3b1 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/wasplab-5a00a7b9 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/research-mhra-data-requirements-to-support-regulatory-decision-making-412cb97a 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/borderline-products-how-to-tell-if-your-product-is-a-medicine-e9e0499f 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/redbook-2000-iv-c-3-b-short-term-toxicity-studies-with-non-rodents-fda-bbabacd5 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/falsified-mounjaro-kwikpen-15mg-pre-filled-pens-gov-uk-11e9e574 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/heart-pump-recall-abiomed-removes-impella-cp-sets-with-smartassist-19bf2b55 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/insulin-pump-recall-insulet-removes-omnipod-pods-22438a54 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/breathing-circuit-set-correction-hamilton-medical-updates-use-instructions-for-b-3eaebdf7 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/transdermal-fentanyl-patches-for-non-cancer-pain-do-not-use-in-opioid-naive-pati-f0433a76 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/idelalisib-zydelig-updated-indications-and-advice-on-minimising-the-risk-of-infe-a4c8692d 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/prolonged-release-opioids-removal-of-indication-for-relief-of-post-operative-pai-1bc0e2af 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/covid-19-vaccines-and-medicines-updates-for-february-2022-gov-uk-bba1883e 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/improving-information-supplied-with-gabapentinoids-pregabalin-gabapentin-benzodi-1122bb2f 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/benzodiazepines-and-opioids-reminder-of-risk-of-potentially-fatal-respiratory-de-e369b2c3 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/5-fluorouracil-intravenous-capecitabine-tegafur-dpd-testing-recommended-before-i-e7120bf5 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/domperidone-for-nausea-and-vomiting-lack-of-efficacy-in-children-reminder-of-con-8b789b1f 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/the-black-triangle-scheme-or-gov-uk-bff7a3f2 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/covid-19-vaccines-and-medicines-updates-for-february-2021-gov-uk-1ff4af80 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/adrenaline-auto-injector-advice-for-patients-gov-uk-8d15d6e0 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/nasal-decongestant-sprays-and-drops-containing-xylometazoline-hydrochloride-oxym-f1270d1d 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/report-misleading-medicines-advertisements-gov-uk-6e6d1777 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/q1b-photostability-testing-of-new-drug-substances-and-products-fda-8289263e 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/draft-guidance-for-industry-labeling-of-plant-based-milk-alternatives-and-volunt-c40c5457 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/emergency-use-authorizations-for-drugs-and-non-vaccine-biological-products-82eebd87 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/coronavirus-covid-19-drugs-9a32956e 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-first-gene-therapy-for-young-children-with-sickle-cell-disease-af816308 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/kao-usa-voluntarily-recalls-some-lots-of-oribe-serene-scalp-densifying-shampoo-dd916e0b 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/what-s-new-related-to-drugs-584370cd 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/magnum-brand-products-may-be-harmful-due-to-hidden-drug-ingredients-3117714e 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/sexual-enhancement-and-energy-product-notifications-cbccfa41 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/eunha-fisheries-co-ltd-issues-allergy-alert-on-undeclared-wheat-soy-and-sesame-i-9aafefc7 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/data-standards-program-strategic-plan-and-board-caae736a 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/cder-data-standards-program-596af54f 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/cder-quality-management-maturity-4861f3e1 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/bridgebio-gets-funding-for-drug-launch-united-buys-into-cell-therapy-62563323 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/untitled-letters-e1f02e26 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/generic-drug-facilities-sites-and-organization-lists-881bd82a 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/newly-added-guidance-documents-475396f1 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/submitting-next-generation-sequencing-data-to-the-division-of-antiviral-products-2989ed36 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/medicines-packaging-labelling-and-patient-information-leaflets-a25c4379 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-warning-statements-for-labels-and-leaflets-of-certain-medicines-2ac85d38 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-best-practice-guidance-on-patient-information-leaflets-0ff663f8 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/drugs-fda-data-files-7de0cc08 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/ipsen-to-buy-swiss-biotech-memo-therapeutics-in-potential-800m-deal-1276303a 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-authorises-gemcitabine-delivery-system-for-adults-with-bcg-unresponsive-hig-7c6874c3 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/5-fda-decisions-to-watch-in-the-third-quarter-of-2026-405b368b 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/financial-transparency-and-efficiency-of-the-prescription-drug-user-fee-act-bios-fc2b03f8 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/abivax-shares-surge-as-worries-subside-over-immune-drug-s-cancer-risk-be1bf1cb 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/table-of-decisions-of-labelling-exemption-requests-falling-under-article-63-of-d-95bfb20d 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/reviews-of-pediatric-studies-conducted-under-bpca-and-pediatric-assessments-cond-a8404542 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/q8-q9-q10-questions-and-answers-appendix-q-as-from-training-sessions-q8-q9-q10-p-9a6d3d98 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/crohn-s-disease-developing-drugs-for-treatment-fda-a5dafd0a 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/enhancing-participation-in-clinical-trials-eligibility-criteria-enrollment-pract-defc1ded 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/cvm-gfi-252-small-entity-compliance-guide-antimicrobial-animal-drug-sales-and-di-04b346d2 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/design-and-analysis-of-shedding-studies-for-virus-or-bacteria-based-gene-therapy-4ee1dfc7 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/interacting-with-the-fda-on-complex-innovative-trial-designs-for-drugs-and-biolo-78cfaf64 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/patient-focused-drug-development-incorporating-clinical-outcome-assessments-into-8a984df2 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/s1a-the-need-for-long-term-rodent-carcinogenicity-studies-of-pharmaceuticals-fda-d9dc7a3e 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/pharmacy-compounding-advisory-committee-roster-38f9fceb 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/oncology-cancer-hematologic-malignancies-approval-notifications-808577ee 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-allogeneic-regulatory-t-cell-based-immunotherapy-with-hspc-and-t-ce-c8d34da5 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-new-treatment-that-uses-donor-immune-cells-to-prevent-serious-compl-776a9aa7 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/ipsen-s-450m-blood-cancer-drug-fda-selects-first-cohort-for-pre-check-pilot-prog-32110501 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/january-march-2026-new-safety-information-or-potential-signals-of-serious-risks--935fbde1 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/new-safety-information-or-potential-signals-of-serious-risks-identified-from-the-579a177e 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/viridian-may-have-edge-over-amgen-in-eye-drug-showdown-analysts-argue-02a3c9ab 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-22-to-26-june-2026-5ee53b79 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/these-biotechs-just-landed-big-fundraising-hauls-here-s-what-they-pitched-to-inv-bca6e69f 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/beeline-ups-its-series-a-round-for-immune-drug-work-848a19e5 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/top-fda-gene-and-cell-therapy-regulator-to-step-down-8f969c79 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-safety-roundup-june-2026-d6a9d3bb 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/class-3-medicines-recall-flamingo-pharma-uk-ltd-flucloxacillin-capsules-bp-500mg-6e855f7a 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-relonchem-limited-gabapentin-relonchem-50m-8d01c66c 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/institutional-review-boards-frequently-asked-questions-fda-49b88b9b 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/use-of-international-standard-iso-10993-1-biological-evaluation-of-medical-devic-8cd18637 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/leveraging-prior-knowledge-in-the-development-of-human-gene-therapy-products-inc-a3229ef6 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/bioavailability-and-bioequivalence-studies-for-nasal-aerosols-and-nasal-sprays-f-a9064166 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/pharmacokinetics-in-patients-with-impaired-hepatic-function-study-design-data-an-97281f37 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/new-and-revised-draft-q-as-on-biosimilar-development-and-the-bpci-act-revision-4-af868f4f 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/safety-assessment-of-genome-editing-in-human-gene-therapy-products-using-next-ge-72054329 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-substantiation-for-dietary-supplement-claims-made-under-se-1057ed04 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/study-data-technical-conformance-guide-technical-specifications-document-fda-57fbab94 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/considering-whether-an-fda-regulated-product-involves-the-application-of-nanotec-51059fab 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/small-entity-compliance-guide-current-good-manufacturing-practice-in-manufacturi-4b4932ac 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/implantable-marker-recall-hologic-removes-biozorb-3d-bioabsorbable-markers-due-t-42373b17 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/fda-selects-seven-participants-for-precheck-pilot-program-to-advance-u-s-drug-ma-952ba2d0 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-borderline-products-medical-devices-and-other-products-8ccb23e3 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-innovation-accelerator-5fbf6f8c 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-mhra-innovation-accelerator-d1c033c4 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/theravance-after-clinical-setbacks-agrees-to-929m-buyout-ffc0bb23 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therap-b2d15bc3 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/content-and-format-of-premarket-notification-510-k-submissions-for-liquid-chemic-8f1b7197 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/q8-q9-and-q10-questions-and-answers-r5-fda-2a993ad9 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/abiomed-introducer-kits-with-impella-heart-pumps-d8c59b8f 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/10-clinical-trials-to-watch-in-the-second-half-of-2026-d0a4b05b 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/orlistat-safety-update-gov-uk-ab1f3a2d 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/labeling-and-effectiveness-testing-sunscreen-drug-products-for-over-the-counter--08db5767 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/high-dose-cyproterone-acetate-potential-risk-of-multiple-meningiomas-gov-uk-006884f0 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/cybersecurity-in-medical-devices-quality-management-system-considerations-and-co-720e92bf 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/information-requests-and-discipline-review-letters-under-the-generic-drug-user-f-f4a4ef38 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/considerations-for-the-use-of-artificial-intelligence-to-support-regulatory-deci-8dcd76d0 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/letters-sent-to-healthcare-professionals-in-january-2016-gov-uk-c773ea6a 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/mesalazine-and-idiopathic-intracranial-hypertension-gov-uk-1034d6fb 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/vitamin-b12-hydroxocobalamin-cyanocobalamin-advise-patients-with-known-cobalt-al-d84d1af8 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/non-steroidal-anti-inflammatory-drugs-nsaids-potential-risks-following-prolonged-c52e8436 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/statins-interactions-and-updated-advice-for-atorvastatin-gov-uk-e3af92cc 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/reviewer-guidance-for-nebulizers-metered-dose-inhalers-spacers-and-actuators-fda-d71de1e0 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/supac-ss-nonsterile-semisolid-dosage-forms-scale-up-and-post-approval-changes-ch-84b22a4c 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/q14-analytical-procedure-development-fda-bef30c2e 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/q2-r2-validation-of-analytical-procedures-fda-71766f70 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/attention-deficit-hyperactivity-disorder-developing-stimulant-drugs-for-treatmen-14319ed8 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-action-levels-for-lead-in-processed-food-intended-for-babi-6b380305 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/marketing-submission-recommendations-for-a-predetermined-change-control-plan-for-8a16b190 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-brancaster-pharma-limited-benzylpenicillin-6dcb003d 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/simvastatin-increased-risk-of-myopathy-at-high-dose-80-mg-gov-uk-a3c703eb 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/temozolomide-risk-of-hepatic-injury-including-fatal-hepatic-failure-updated-warn-104e0781 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/intravenous-iron-and-serious-hypersensitivity-reactions-strengthened-recommendat-2fecdc50 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/levothyroxine-new-prescribing-advice-for-patients-who-experience-symptoms-on-swi-01e469d4 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/draft-guidance-for-industry-hazard-analysis-and-risk-based-preventive-controls-f-f0dab420 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/ingenol-mebutate-gel-picato-increased-incidence-of-skin-tumours-seen-in-some-cli-f2bcef0a 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-food-labeling-guide-fda-8efdda75 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/general-considerations-for-animal-studies-intended-to-evaluate-medical-devices-f-708a6463 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-august-2022-gov-582296df 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-the-seafood-list-fda-s-guide-to-determine-acceptable-seafo-d83e79f4 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/letters-and-drug-alerts-sent-to-healthcare-professionals-in-november-2020-gov-uk-841b9414 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/medical-device-alerts-issued-in-march-2018-gov-uk-bc1dec44 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/show-your-support-for-reporting-suspected-adverse-drug-reactions-gov-uk-a9a237f9 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/document-a097c753 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/u-s-food-and-drug-administration-24dc1aba 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guideline-on-the-clinical-evaluation-of-ant-073a20f2 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/la-ceiba-foods-latin-market-inc-recalls-cottage-cheese-products-because-of-possi-f50e862a 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/total-nutrition-inc-recalls-organic-moringa-products-following-supplier-initiate-7f60dcc8 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/fda-accepts-replimune-filing-merck-kgaa-drops-11b-on-life-sciences-services-4576399b 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/at-bio-tension-over-china-biotech-deal-regulation-looms-0c58d81a 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guideline-on-data-requirements-for-authoris-17899850 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guideline-on-data-requirements-for-the-repl-0439fb18 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/register-medical-devices-to-place-on-the-market-593f13cf 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/alkermes-incoming-ceo-has-a-plan-to-outplay-lilly-and-takeda-17d042ca 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/on-second-try-acadia-drug-gets-nod-from-european-regulators-db0a7be5 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/fda-proposes-rule-that-would-help-hold-foreign-tobacco-product-manufacturers-acc-f610d436 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/remifentanil-hydrochloride-for-injection-out-of-specification-assay-impurity-71a02afc 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp--d5b1c9ac 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/first-aid-kit-recall-north-american-rescue-issues-correction-for-first-aid-kits--86991984 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/revival-animal-health-llc-voluntarily-recalls-canine-and-gm-milk-replacers-due-t-8fc154ce 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/lehi-valley-trading-company-issues-allergy-alert-on-undeclared-peanuts-in-chocol-1b70e70c 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/remix-to-go-public-in-reverse-merger-with-once-high-flying-passage-bio-a598bcce 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/antares-gets-105m-from-novartis-for-new-cancer-drugs-bda76880 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/bear-stewart-llc-issues-allergy-alert-on-undeclared-soy-in-bakr-brown-butter-cho-2c388826 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/protecting-patients-ensuring-safe-quality-and-effective-health-products-082e316e 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/spiriva-capsules-out-of-specification-uniformity-of-delivered-dose-5e2f0aa0 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-mhra-innovation-office-guidance-and-support-e1ebaa67 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/ionis-with-new-fda-nod-hits-a-commercial-inflection-point-81d56b9f 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/investors-pour-115m-into-rq-bio-in-search-of-a-preventive-flu-drug-34ca3277 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/to-wall-street-psychedelics-biotechs-are-more-teammates-than-rivals-24aee8af 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/notice-register-of-authorised-online-sellers-of-medicines-in-northern-ireland-f6d48fed 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/infinion-cx-contact-lead-kit-faa6091b 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/uhi-4-high-flow-insufflation-system-insufflator-6c3a3b87 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/argon-medical-devices-l-cath-picc-and-midline-catheters-455134e7 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/655-million-people-still-living-without-electricity-underscore-urgent-need-to-de-14cc57c1 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-15-to-19-june-2026-8fcc061e 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/optima-xr240amx-x-ray-system-7bc1aa4b 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/a-t-s-4000-ts-tourniquet-systems-single-and-dual-hose-with-cpc-connectors-4251612b 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/hoffmann-ii-carbon-connecting-rod-f6e1e4c0 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/who-urges-scale-up-of-newborn-screening-to-improve-early-detection-and-care-of-b-30154a99 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/annex-22-expert-workshop-draft-agenda-day-1-session-with-interested-parties-05b2d1a2 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/penumbra-system-red-68-reperfusion-catheter-3c777a95 2026-06-22 monthly 0.6 https://platform.ontopharmatech.com/news/gyrus-acmi-classic-series-continuous-flow-resectoscope-5547f029 2026-06-22 monthly 0.6 https://platform.ontopharmatech.com/news/cyberknife-treatment-delivery-system-f5c6a317 2026-06-22 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-16--e0f143a8 2026-06-19 monthly 0.6 https://platform.ontopharmatech.com/news/bd-maxplus-connector-minibore-extension-set-bac730b0 2026-06-19 monthly 0.6 https://platform.ontopharmatech.com/news/faradrive-steerable-sheath-1684d579 2026-06-19 monthly 0.6 https://platform.ontopharmatech.com/news/update-on-the-pathways-clinical-trial-8f3ab389 2026-06-19 monthly 0.6 https://platform.ontopharmatech.com/news/warning-on-promoting-newly-licensed-prescription-only-medicines-and-unlicensed-m-a0e4959e 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/atellica-ch-enzymatic-hemoglobin-a1c-a1c-e-assay-3622a559 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/med-rx-wound-care-kit-55d6ff38 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-advice-for-consumers-1866cace 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-catheter-introducer-issue-from-abiomed-and-oscor-b44cdefd 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/catheter-recall-expansion-medline-industries-removes-reprocessed-electrophysiolo-c2bbcdcb 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-covid-19-test-validation-approved-products-563bfe6e 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/polyflex-powder-for-suspension-cracked-vials-f9ff2a07 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/plum-precision-iv-pumps-32bf4719 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/single-use-distal-cover-68693bfe 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/artis-icono-ceiling-d3af4482 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/ace-inhibitors-be-aware-of-the-distinction-between-bradykinin-and-histamine-medi-12b93afd 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/lancora-tablets-broken-partial-tablets-in-blister-pack-59c83e7b 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/unauthorized-soft-shelled-hyperbaric-chambers-may-pose-serious-health-risks-2026-d5d184ae 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/ge-healthcare-integrated-and-stand-alone-resuscitation-systems-71237eee 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/class-3-medicines-recall-orbit-pharma-limited-cyclizine-lactate-50-mg-ml-solutio-7f90cc2e 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/committee-for-advanced-therapies-cat-rules-of-procedure-55bf4fa5 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-convenience-kit-issue-from-windstone-medical-packaging-inc-5303c45a 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/disruptions-in-availability-of-breast-biopsy-needles-letter-to-health-care-provi-9ea55e41 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/unique-liaison-programme-set-to-reinforce-close-collaboration-between-mhra-and-f-34a9ce7f 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-8-12-june-2026-4ca9dcb1 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/iris-guide-to-registration-and-rpis-8b62a3c5 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/iris-guide-for-applicants-how-to-create-submit-and-manage-iris-applications-for--6f8ded33 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/ema-management-board-highlights-of-june-2026-meeting-1d2467d4 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/anesthesia-machine-correction-draeger-inc-issues-correction-for-atlan-a350-and-a-64f1ea11 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-scientific-leader-recognised-in-2026-king-s-birthday-honours-3cbeb358 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/lower-dose-needle-free-allergy-treatment-approved-for-younger-children-9ee6777f 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/products-management-services-pms-implementation-of-international-organization-fo-efb39cf9 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-8-1-c7cbf4de 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/convenience-kit-correction-medline-issues-correction-for-kits-containing-huons-b-cb0e0487 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/accolade-pacemaker-devices-by-boston-scientific-and-potential-need-for-early-dev-a759a90f 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/beekeeper-s-naturals-issues-voluntary-nationwide-recall-of-beekeeper-s-naturals--3f522cdc 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/first-glp-1-tablet-for-weight-loss-approved-in-the-uk-3765e19c 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-landmark-report-reveals-public-views-on-ai-in-healthcare-4619a0ad 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/regulation-of-medical-devices-in-northern-ireland-8f200ed4 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/contact-the-mhra-f18d19b8 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-the-impact-of-mutual-recognition-agreement-mra-between--d2b9ad60 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/etms-70-mm-cooled-coil-c1d5e744 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/aptima-hiv-quant-dx-assay-hcv-quant-dx-assay-and-hbv-quant-assay-software-fc04aa22 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/regulation-of-ai-in-healthcare-6809d5df 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/research-national-commission-into-the-regulation-of-ai-in-healthcare-research-en-519a8337 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/ema-s-2025-annual-report-shows-strong-approval-numbers-for-human-and-veterinary--2f6afafb 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/medical-devices-ask-for-a-regulatory-advice-meeting-from-the-mhra-a0c21f18 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-positive-pressure-breathing-device-issue-from-baxter-4bbd5345 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/heart-pump-correction-abiomed-issues-correction-for-automated-impella-controller-2bce4db7 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-labeling-changes-for-over-the-counter-otc-weight-loss-drug-alli-orl-94448cd6 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/selenia-dimensions-2d-3d-mammography-systems-6844ebba 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/nicotine-pouch-recall-no-market-authorization-4e120e8d 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/opportunities-for-patients-and-the-public-to-be-involved-in-the-work-of-the-mhra-b4b996db 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/pioneering-ai-health-innovations-regulatory-sandbox-launched-19698e29 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-launches-ai-sandbox-to-accelerate-medicines-development-and-improve-safety-13a4cef5 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/nipocalimab-imaavy-authorised-to-treat-adults-and-adolescents-with-generalised-m-386b56fa 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/guedel-airway-34f9c069 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/promotional-material-national-ai-commission-ask-me-anything-817f4b03 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-ai-airlock-simulation-workshops-b22f22c3 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-ai-airlock-sandbox-phase-2-programme-report-937166ab 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-advertising-investigations-may-2026-7776c6f0 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-modifying-a-clinical-trial-approval-8af5aa07 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/pms-fluconazole-50-mg-tablets-incorrect-quantity-of-tablets-825bb41d 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/baxter-corporation-products-recall-blue-cap-breakage-8856751f 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-1-5-june-2026-d363db39 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-cadila-pharmaceuticals-limited-mirtazapine-9dda28bc 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/decision-human-and-veterinary-medicines-register-of-licensed-manufacturing-sites-7ab83885 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/notice-register-of-brokers-authorised-to-deal-in-human-medicines-f1236e9d 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/decision-medicines-new-manufacturing-and-wholesale-dealer-licences-acc36634 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/notice-medicines-terminated-and-cancelled-manufacturing-and-wholesale-dealer-lic-6a491726 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/decision-human-medicines-register-of-licensed-wholesale-distribution-sites-14233e64 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-review-of-the-benefits-and-risks-of-avacopan-b00cf505 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/find-product-information-about-medicines-64c4b7da 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/member-states-contact-points-for-translations-review-bb70c6f3 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/checklist-for-the-submission-of-day-215-product-information-annexes-for-a-post-o-2deea3f1 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/adjuvanted-trivalent-influenza-vaccine-authorised-for-adults-aged-50-and-over-3da1daae 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/research-mhra-public-sector-equality-duty-report-2025-2026-d2eb421b 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/harmony-delivery-catheter-system-a1637260 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/philips-allura-xper-systems-b868a9f4 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/giraffe-omnibed-carestation-2353ccb6 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-teva-uk-ltd-ponlimsi-denosumab-60mg-soluti-5eb80899 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/sahpra-strengthens-industry-collaboration-to-improve-access-to-safe-medicines-dc7a0973 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/resmetirom-rezdiffra-authorised-to-treat-metabolic-dysfunction-associated-steato-8518202c 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-development-of-a-reflection-paper-on-the-use-of-external-co-fa288631 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/ema-ama-and-african-regulatory-authorities-join-forces-on-ebola-outbreak-respons-1d696956 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/iceman-classic3-27f7652d 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/artis-icono-ceiling-floor-and-biplane-systems-91a69f19 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/dexcom-g7-sensor-1-pack-e005780b 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/intellicuff-fd685cbe 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-becton-dickinson-uk-ltd-chloraprep-2-1ml-and-chloraprep-79d74fe1 2026-06-02 monthly 0.6 https://platform.ontopharmatech.com/news/kala-red-light-face-mask-114da307 2026-06-02 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-25-to-29-may-2026-1ed9fa53 2026-06-02 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-catheter-introducer-kit-issue-from-abiomed-97561092 2026-06-02 monthly 0.6 https://platform.ontopharmatech.com/news/pharmacovigilance-related-regulatory-recommendations-for-centrally-authorised-ve-0933567e 2026-06-01 monthly 0.6 https://platform.ontopharmatech.com/news/united-for-health-ema-in-worldpride-2026-68988e8f 2026-05-31 monthly 0.6 https://platform.ontopharmatech.com/news/decision-medical-devices-given-exceptional-use-authorisations-624a4b9f 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/two-arrested-during-the-mhra-s-largest-ever-seizure-of-unlicensed-weight-loss-me-12e0d837 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/relay-pro-thoracic-stent-graft-system-84893ed2 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/omnipod-insulin-management-system-omnipod-94e62929 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/hizentra-the-appearance-is-out-of-specification-in-the-affected-lot-5dbcef34 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/etf-recommends-updating-covid-19-vaccines-to-target-xfg-variant-a2a6df90 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/rilzabrutinib-authorised-to-treat-adults-with-immune-thrombocytopenia-when-prior-582263b2 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/list-of-centrally-authorised-products-with-safety-related-changes-to-the-product-d6be3582 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-need-for-revision-of-the-guideline-on-the-development-of-me-14ec63f6 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/dexcom-uncovers-theft-of-scrapped-product-notifies-potentially-impacted-users-ea907ad2 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/pediatric-care-bed-correction-kayserbetten-issues-correction-for-kayserbett-ida--bf1a5487 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-18-22-may-2026-91f842e8 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/product-management-services-pms-implementation-of-international-organization-for-05cd872f 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/precautionary-recall-of-blood-pressure-medication-crescent-pharma-limited-ramipr-e07055a4 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-crescent-pharma-limited-ramipril-2-5-mg-capsules-el-26--1e75b30b 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-safety-roundup-may-2026-8bb1e707 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/ge-healthcare-aw-server-40bab407 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/hamilton-medical-ag-breathing-set-mri-efab03da 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/gore-tag-thoracic-branch-endoprosthesis-side-branch-component-f1db351a 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/ventilator-correction-philips-issues-correction-for-trilogy-evo-platform-ventila-b2c3f3e4 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/cryoprobe-recall-erbe-usa-removes-flexible-cryoprobes-d2e50f69 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/allurion-gastric-balloon-updated-safety-information-due-to-the-risks-of-gastric--dd237927 2026-05-27 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-welcomes-jason-bonander-as-he-starts-his-role-as-chief-digital-and-technolo-d2c56017 2026-05-27 monthly 0.6 https://platform.ontopharmatech.com/news/eu-recommendations-for-2026-2027-seasonal-flu-vaccine-composition-95f23ea4 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/second-amended-biologics-working-party-vaccines-quality-operational-expert-group-90411b1b 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/amended-biologics-working-party-vaccines-quality-operational-expert-group-bv-oeg-ac04d185 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/don-t-let-this-heatwave-affect-your-medicines-three-important-tips-from-the-mhra-e899be48 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/dialysis-catheter-kit-recall-arrow-international-removes-dialysis-catheter-kits--bea9881b 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/manifold-recall-medline-removes-namic-star-off-handle-manifolds-7c76d321 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/insulet-initiates-voluntary-medical-device-correction-for-certain-omnipod-pods-i-e9c5a466 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/sahpra-and-the-sapc-crack-down-on-unlawful-manufacturing-of-unregistered-glp-1-g-b8ddc516 2026-05-23 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-mhra-performance-data-6366ab1e 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-periodic-safety-update-report-single-assessment-psusa-g-8f1e4e66 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/guideline-on-good-pharmacovigilance-practices-gvp-module-vii-periodic-safety-upd-d5196f0c 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-19--57f2a0fb 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/merlin-3650-patient-care-system-pcs-96ec0f56 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/gsp-neonatal-galt-kit-78b0cfe9 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/red-rubber-latex-catheters-ba496803 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp--372ecf09 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/new-medicine-for-two-types-of-pulmonary-fibrosis-165c5ee1 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/project-orbis-66e1e55d 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/decision-suspended-and-revoked-licences-and-registrations-for-manufacturers-and--25d7d043 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/decision-human-medicines-register-of-electronic-export-certificates-bd23bae1 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/lifepak-15-v4-spco-spmet-sensors-93acea95 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/neurological-sponges-0ca632b2 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/kirkland-signature-women-50-may-contain-the-presence-of-foreign-matter-metal-fra-4357c4bc 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/ema-closed-on-whit-monday-25-may-09741310 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/cincinnati-surgical-branded-blades-and-scalpels-aa8dab4c 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-on-the-details-of-the-classification-of-variations-requiring-assessment-e7e23921 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-heart-pump-controller-issue-from-abiomed-132c70f2 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/automated-compounding-system-recall-omnicell-removes-syringe-labels-used-with-th-46865023 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/ventilator-recall-react-health-removes-vocsn-v-pro-ventilators-95256843 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/draft-rare-disease-therapies-regulatory-framework-57ac3ba5 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/landmark-new-plans-bring-treatments-for-rare-diseases-a-step-closer-310fcaa2 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-consults-on-new-regulatory-framework-to-make-uk-a-global-leader-in-rare-dis-ab55da32 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/amiodarone-reminder-of-risks-of-treatment-and-need-for-patient-monitoring-and-su-96165b15 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/risk-of-severe-harm-from-use-of-incorrect-giving-administration-set-for-blood-tr-eae7427a 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/eu-tracks-progress-towards-2030-clinical-trial-targets-70ada5f5 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-mhra-nice-real-world-evidence-scientific-dialogue-984df2a0 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/thoracic-stent-graft-recall-bolton-medical-removes-relay-pro-system-a504f753 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/kimal-procedure-packs-containing-recalled-components-namic-angiographic-syringe--36ec301c 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-11-to-15-may-2026-de63c025 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-innovative-licensing-and-access-pathway-ilap-ae18eaa4 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/international-council-for-harmonisation-of-technical-requirements-for-pharmaceut-f7f49161 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-medicines-and-healthcare-products-regulatory-agency-spending-o-57d6cc70 2026-05-19 monthly 0.6